Bumrungrad Hospital PCL's revenue for the
three
months ended in Dec. 2025 was $207.0 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $777.5 Mil.
Bumrungrad Hospital PCL's Revenue per Share for the
three
months ended in Dec. 2025 was $0.24.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.90.
Warning Sign:
Bumrungrad Hospital PCL revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Bumrungrad Hospital PCL was -2.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 6.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 18.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 3.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Bumrungrad Hospital PCL's highest 3-Year average Revenue per Share Growth Rate was 27.30% per year. The lowest was -12.10% per year. And the median was 7.75% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bumrungrad Hospital PCL Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's Revenue distribution charts can be found below:
* The bar in red indicates where Bumrungrad Hospital PCL's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $777.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bumrungrad Hospital PCL (BUGDF) has a Revenue of $777.5 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Bumrungrad Hospital PCL and its competitors.
Is Bumrungrad Hospital PCL's Revenue too high?
Bumrungrad Hospital PCL's current Revenue is $777.5 Mil. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's Revenue compare to HCA and THC?
Bumrungrad Hospital PCL's Revenue of $777.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Bumrungrad Hospital PCL and its competitors. Bumrungrad Hospital PCL's current Revenue is $777.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current Revenue of $777.5 Mil. The stock's GF Value™ is $5.79, compared to a current price of $4.75 — trading 18% below its estimated fair value. The current Revenue is $777.5 Mil. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current Revenue is $777.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued.
The current stock price of $4.75 is trading 18% below its estimated GF Value™ of $5.79.
Key valuation signals for BUGDF:
Revenue: $777.5 Mil
GF Value™: $5.79 vs. price of $4.75 (18% below fair value)
No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score
Get the complete analysis for BUGDF
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUGDF has been successfully added to your 
